Surface Guided Radiation Therapy for Left Breast Cancer
Optical Surface Monitoring Technology-Guided Large-Segment Radiotherapy for Breast Cancer
Recruiting
Phase 2
Phase 3
Interventional Study
Breast Cancer
Optical Surface Monitoring Technology
Large-segment Radiotherapy
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 – 70
- Sex
- Female
- Trial phase
- Phase 2/3
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 556 (estimated)
- Sponsor
- Peking Union Medical College Hospital · Other
Who this trial is looking for
This trial is looking for women with left breast cancer who have had surgery and need radiation treatment. Participants will receive a new radiation technique that aims to improve treatment accuracy and heart safety.
Are You a Good Fit for This Trial?
You may be able to join if
- I have had surgery for left breast cancer.
- I need radiation treatment for my left breast or upper chest.
- I can hold my breath for over 35 seconds and repeat it at least 6 times.
- I have not received chemotherapy before surgery.
- I do not have any active heart disease.
- I can sign the consent form voluntarily.
You may not be able to join if
- I have cancer in both breasts.
- I do not have a confirmed cancer diagnosis.
- My cancer has spread to distant parts of my body.
- I have received chemotherapy before surgery or had breast reconstruction.
- I have had radiation therapy to my chest area before.
- I have had radiation therapy to my abdomen or pelvis before.
- I have another cancer besides this one.
- I have serious heart problems.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study is a single-center,blinded, efficacious, phase III randomized clinical trial initiated by investigators. The primary objective is to investigate the use of Surface Guided Radiation Therapy (SGRT) in combination with Deep Inspiration Breath Hold (DIBH) technique for left breast cancer treatment, compared to traditional laser alignment with free breathing treatment. This approach offers s…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Patients who have undergone breast-conserving surgery or modified radical mastectomy for left breast cancer;
2. Planned whole-breast ± supraclavicular region, chest wall ± supraclavicular region radiotherapy;
3. Able to perform deep inspiration breath-hold technique with brea…
Contacts